Free Trial
NYSE:WST

West Pharmaceutical Services (WST) Stock Price, News & Analysis

West Pharmaceutical Services logo
$223.38 +2.33 (+1.05%)
As of 01:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About West Pharmaceutical Services Stock (NYSE:WST)

Key Stats

Today's Range
$219.46
$223.19
50-Day Range
$205.67
$229.27
52-Week Range
$187.43
$352.33
Volume
149,630 shs
Average Volume
733,951 shs
Market Capitalization
$16.05 billion
P/E Ratio
34.95
Dividend Yield
0.38%
Price Target
$320.00
Consensus Rating
Moderate Buy

Company Overview

West Pharmaceutical Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

WST MarketRank™: 

West Pharmaceutical Services scored higher than 96% of companies evaluated by MarketBeat, and ranked 61st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    West Pharmaceutical Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    West Pharmaceutical Services has only been the subject of 3 research reports in the past 90 days.

  • Read more about West Pharmaceutical Services' stock forecast and price target.
  • Earnings Growth

    Earnings for West Pharmaceutical Services are expected to grow by 18.73% in the coming year, from $6.62 to $7.86 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of West Pharmaceutical Services is 34.95, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of West Pharmaceutical Services is 34.95, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.61.

  • Price to Earnings Growth Ratio

    West Pharmaceutical Services has a PEG Ratio of 5.52. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    West Pharmaceutical Services has a P/B Ratio of 6.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about West Pharmaceutical Services' valuation and earnings.
  • Percentage of Shares Shorted

    1.06% of the float of West Pharmaceutical Services has been sold short.
  • Short Interest Ratio / Days to Cover

    West Pharmaceutical Services has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in West Pharmaceutical Services has recently decreased by 77.63%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    West Pharmaceutical Services has a dividend yield of 0.37%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    West Pharmaceutical Services does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of West Pharmaceutical Services is 13.19%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 10.69% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.

  • Read more about West Pharmaceutical Services' dividend.
  • Percentage of Shares Shorted

    1.06% of the float of West Pharmaceutical Services has been sold short.
  • Short Interest Ratio / Days to Cover

    West Pharmaceutical Services has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in West Pharmaceutical Services has recently decreased by 77.63%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    West Pharmaceutical Services has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for West Pharmaceutical Services this week, compared to 16 articles on an average week.
  • Search Interest

    Only 4 people have searched for WST on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, West Pharmaceutical Services insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.57% of the stock of West Pharmaceutical Services is held by insiders.

  • Percentage Held by Institutions

    93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about West Pharmaceutical Services' insider trading history.
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Stock News Headlines

West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
West to Host Second-Quarter 2025 Conference Call
See More Headlines

WST Stock Analysis - Frequently Asked Questions

West Pharmaceutical Services' stock was trading at $327.56 at the beginning of 2025. Since then, WST shares have decreased by 31.8% and is now trading at $223.38.

West Pharmaceutical Services, Inc. (NYSE:WST) issued its quarterly earnings results on Thursday, April, 24th. The medical instruments supplier reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.23. The firm's revenue was up .4% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and others.

Top institutional shareholders of West Pharmaceutical Services include Seilern Investment Management Ltd (0.60%), Riverbridge Partners LLC (0.53%), Assenagon Asset Management S.A. (0.21%) and Rockland Trust Co. (0.11%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Quintin J Lai, Annette F Favorite, Bernard Birkett, Cindy Reiss-Clark, Silji Abraham, Chad Winters and Charles Witherspoon.
View institutional ownership trends
.

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Home Depot (HD), Chevron (CVX) and Netflix (NFLX).

Company Calendar

Last Earnings
4/24/2025
Record date for 5/7 Dividend
4/30/2025
Ex-Dividend for 5/7 Dividend
4/30/2025
Dividend Payable
5/07/2025
Today
7/16/2025
Next Earnings (Estimated)
7/24/2025
Record date for 8/6 Dividend
7/30/2025
Ex-Dividend for 8/6 Dividend
7/30/2025
Dividend Payable
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NYSE:WST
CIK
105770
Employees
10,600
Year Founded
1923

Price Target and Rating

High Price Target
$400.00
Low Price Target
$245.00
Potential Upside/Downside
+44.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
$6.37
Trailing P/E Ratio
34.68
Forward P/E Ratio
33.37
P/E Growth
5.52
Net Income
$492.70 million
Net Margins
16.13%
Pretax Margin
19.64%
Return on Equity
18.23%
Return on Assets
13.51%

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
2.77
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$2.89 billion
Price / Sales
5.49
Cash Flow
$8.87 per share
Price / Cash Flow
24.91
Book Value
$37.04 per share
Price / Book
5.96

Miscellaneous

Outstanding Shares
71,850,000
Free Float
71,435,000
Market Cap
$15.87 billion
Optionable
Optionable
Beta
1.09

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:WST) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners